tirzepatide 3.75 mg Weight Loss Injections Tirzepatide: Injection Home Kit –

Cardiometabolic outcome trials Pooled analysis of Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) 1-5 (assessing semaglutide at lower doses of 0.5 and 1 mg doses for the treatment of T2D), found semaglutide had a similar weight reduction, and glycaemic control, efficacy in older and younger adults

Avoid Overeating: Overloading the stomach can amplify nausea and bloating

The careful comparison is: Mounjaro has strong evidence for weight loss and triglyceride improvement, with broader evidence of modest lipid improvements [1,6,7]

You may be eligible for Semaglutide if: Eligibility is determined during a private discovery call with our clinic provider

However, remember that individual results can vary